Baseline characteristics of study population | n (%, ± SD) |
---|---|
Patients at all | 30 (100) |
Age (years) | 55.33 ± 10.48 |
Height (cm) | 175 ± 5.9 |
Weight (kg) | 86 ± 25.6 |
BMI (kg/m2) | 28.23 ± 7.75 |
Sex | |
Men | 21 (70) |
Women | 9 (30) |
Follow-up in days | 164.17 ± 153.175 |
Indication for catheterization | |
Instable angina | 18 (60) |
Diagnostic angiography | 7 (23.3) |
NSTEMI | 4 (13.3) |
STEMI | 1 (3.3) |
Procedure time (min) | 25.3 ± 15.45 |
Antiplatelet therapy | |
Aspirin | 10 (33.3) |
Aspirin and clopidogrel | 12 (40%) |
None | 8 (26.7%) |
Medical therapy of RAO | |
LMWH | 10 (52.6) |
Rivaroxaban | 6 (31.6) |
Apixaban | 1 (5.3) |
Single alprostadil | 2 (10.5) |
Duration of alprostadil therapy (days) | 7.91 ± 3.44 |
Side of occlusion | |
Left radial artery | 20 (66.7) |
Right radial artery | 10 (33.3) |
Length of occlusion | |
Distal forearm | 13 (43.3) |
Distal and middle forearm | 6 (20) |
Whole forearm | 11 (36.7) |
No symptoms | 14 (46.7) |
Symptoms | 16 (53.3) |
Pain | 16 (100) |
Paresthesia | 2 (12.5) |
Weakness | 1 (6.25) |